{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:58:33Z","timestamp":1787003913246,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1038\/sj.bjc.6600413","type":"journal-article","created":{"date-parts":[[2002,9,3]],"date-time":"2002-09-03T13:28:41Z","timestamp":1031059721000},"page":"1854-1857","source":"Crossref","is-referenced-by-count":88,"title":["Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients"],"prefix":"10.1038","volume":"86","author":[{"given":"F","family":"Graziano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bisonni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Rovidati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Mencarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Canestrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Baldelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"De Gaetano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Giordani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,6,11]]},"reference":[{"key":"BF6600413_CR1","first-page":"121","volume":"9","author":"AC Bach","year":"1983","unstructured":"Bach, AC, Schirardin, H, Sihr, MO, Storck, D (1983) Free and total carnitine in human serum after oral ingestion of L-carnitine. Diabete Metab 9: 121\u2013124","journal-title":"Diabete Metab"},{"key":"BF6600413_CR2","first-page":"22","volume":"63","author":"H Baker","year":"1993","unstructured":"Baker, H, Frank, O, DeAngelis, B, Baker, ER (1993) Absorption and excretion of L-carnitine during single or multiple dosings in humans. Int J Vitam Nutr Res 63: 22\u201326","journal-title":"Int J Vitam Nutr Res"},{"key":"BF6600413_CR3","first-page":"183","volume":"29","author":"A Bizzi","year":"1978","unstructured":"Bizzi, A, Mingardi, G, Codegoni, AM, Mecca, G, Garattini, S (1978) Accelerated recovery of post-dialysis plasma carnitine fall by oral carnitine. Biomedicine 29: 183\u2013184","journal-title":"Biomedicine"},{"key":"BF6600413_CR4","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/S0272-6386(05)80019-8","volume":"37","author":"EP Brass","year":"2001","unstructured":"Brass, EP, Adler, S, Sietsema, KE, Hiatt, WR, Orlando, AM, Amato, A (2001) Intravenous L-Carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients. Am J Kidney Dis 37: 1018\u20131028","journal-title":"Am J Kidney Dis"},{"key":"BF6600413_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1054\/bjoc.1999.0933","volume":"82","author":"R Breitkreutz","year":"2000","unstructured":"Breitkreutz, R, Babylon, A, Hack, V, Schuster, K, Tokus, M, Bohles, H, Hagmuller, E, Edler, L, Holm, E, Droge, W (2000) Effect of carnitine on muscular glutamate uptake and intramuscular glutathione in malignant diseases. Br J Cancer 82: 399\u2013403","journal-title":"Br J Cancer"},{"key":"BF6600413_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/mus.880160205","volume":"16","author":"Y Campos","year":"1993","unstructured":"Campos, Y, Huertas, R, Lorenzo, G, Bautista, J, Gutierrez, E, Aparicio, M, Alesso, L, Arenas, J (1993) Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy. Muscle Nerve 16: 150\u2013153","journal-title":"Muscle Nerve"},{"key":"BF6600413_CR7","first-page":"574a","volume":"18","author":"CS Cleeland","year":"1999","unstructured":"Cleeland, CS, Demetri, GD, Glaspy, J, Cella, DF, Portenoy, RK, Cremieux, PY, Itri, LM (1999) Identifying hemoglobin level for optimum quality of life: results of an incremental analysis. Proc Am Soc Clin Oncol 18: 574a (abstract 2215)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6600413_CR8","first-page":"307","volume":"28","author":"T Deufel","year":"1990","unstructured":"Deufel, T (1990) Determination of L-carnitine in biological fluids and tissues. J Clin Chem Clin Biochem 28: 307\u2013311","journal-title":"J Clin Chem Clin Biochem"},{"key":"BF6600413_CR9","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2273::AID-CNCR24>3.0.CO;2-B","volume":"85","author":"F Dimeo","year":"1999","unstructured":"Dimeo, F, Stieglitz, R, Novelli-Fischer, U, Keul, J (1999) Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 85: 2273\u20132277","journal-title":"Cancer"},{"key":"BF6600413_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/07315724.1989.10720288","volume":"8","author":"WL Dodson","year":"1989","unstructured":"Dodson, WL, Sachan, DS, Krauss, S, Hanna, W (1989) Alterations of serum and urinary carnitine profiles in cancer patients: hypothesis of possible significance. J Am Coll Nutr 8: 133\u2013142","journal-title":"J Am Coll Nutr"},{"key":"BF6600413_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF00555510","volume":"35","author":"P Farper","year":"1988","unstructured":"Farper, P, Elwin, CE, Cederblad, G (1988) Pharmacokinetics of bolus and intravenous and oral doses of L-Carnitine in healthy subjects. Eur J Clin Pharmacol 35: 69\u201375","journal-title":"Eur J Clin Pharmacol"},{"key":"BF6600413_CR12","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/jnci\/91.19.1616","volume":"91","author":"JE Groopman","year":"1999","unstructured":"Groopman, JE, Itri, LM (1999) Chemotherapy-induced anaemia in adults: incidence and treatment. J Natl Cancer Inst 91: 1616\u20131634","journal-title":"J Natl Cancer Inst"},{"key":"BF6600413_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s002280050504","volume":"54","author":"W Heuberger","year":"1998","unstructured":"Heuberger, W, Berardi, S, Jacky, E, Pey, P, Krahenbuhl, S (1998) Increased urinary excretion of carnitine in patients treated with cisplatin. Eur J Clin Pharmacol 54: 503\u2013508","journal-title":"Eur J Clin Pharmacol"},{"key":"BF6600413_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s002800050963","volume":"44","author":"NP Marthaler","year":"1999","unstructured":"Marthaler, NP, Visarius, T, Kupfer, A, Lauterburg, BH (1999) Increased urinary losses of carnitine during ifosfamide chemotherapy. Cancer Chemother Pharmacol 44: 170\u2013174","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF6600413_CR15","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/jnci\/93.12.892","volume":"93","author":"C McNeil","year":"2001","unstructured":"McNeil, C (2001) Cancer fatigue: one drug fails but more are in the pipeline. J Natl Cancer Inst 93: 892\u2013893","journal-title":"J Natl Cancer Inst"},{"key":"BF6600413_CR16","first-page":"593a","volume":"18","author":"GR Morrow","year":"1999","unstructured":"Morrow, GR, Hickok, JT, Lindke, JL, Moore, Jr DF (1999) Longitudinal assessment of fatigue in consecutive chemotherapy patients: A URCC CCOP study. Proc Am Soc Clin Oncol 18: 593a (abstract 2293)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6600413_CR17","first-page":"384a","volume":"20","author":"GR Morrow","year":"2001","unstructured":"Morrow, GR, Hickok, JT, Raubertas, RF, Flynn, PJ, Hynes, HE, Banerjee, TK, Kirshner, JJ, King, DK (2001) Effect of an SSRI antidepressant on fatigue and depression in seven hundred thirty-eight cancer patients treated with chemotherapy: a URCC CCOP study. Proc Am Soc Clin Oncol 20: 384a (abstract 1531)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6600413_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<339::AID-JCP4>3.0.CO;2-B","volume":"182","author":"G Peluso","year":"2000","unstructured":"Peluso, G, Nicolai, R, Reda, E, Benatti, P, Barbarisi, A, Calvani, M (2000) Cancer and anticancer therapy-induced modifications on metabolism mediated by the carnitine system. J Cell Physiol 182: 339\u2013343","journal-title":"J Cell Physiol"},{"key":"BF6600413_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.4-1-1","volume":"4","author":"RK Portenoy","year":"1999","unstructured":"Portenoy, RK, Itri, LM (1999) Cancer-related fatigue: guidelines for evaluation and management. Oncologist 4: 1\u201310","journal-title":"Oncologist"},{"issue":"Suppl 2","key":"BF6600413_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2354.1996.tb00248.x","volume":"5","author":"A Richardson","year":"1996","unstructured":"Richardson, A, Ream, E (1996) The experience of fatigue and other symptoms in patients receiving chemotherapy. Eur J Cancer Care 5: Suppl 2 24\u201330","journal-title":"Eur J Cancer Care"},{"key":"BF6600413_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/07357900009023057","volume":"18","author":"AL Schwartz","year":"2000","unstructured":"Schwartz, AL, Nail, LM, Chen, S, Meek, P, Barsevick, AM, King, ME, Jones, LS (2000) Fatigue patterns observed in patients receiving chemotherapy and radiotherapy. Cancer Invest 18: 11\u201319","journal-title":"Cancer Invest"},{"key":"BF6600413_CR22","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1023\/A:1008318932641","volume":"11","author":"P Stone","year":"2000","unstructured":"Stone, P, Richardson, A, Ream, A, Smith, AG, Kerr, DJ, Kearney, N (2000) Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Ann Oncol 11: 971\u2013975","journal-title":"Ann Oncol"},{"key":"BF6600413_CR23","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/jnci\/89.23.1763","volume":"89","author":"MJ Tisdale","year":"1997","unstructured":"Tisdale, MJ (1997) Biology of cachexia. J Natl Cancer Inst 89: 1763\u20131773","journal-title":"J Natl Cancer Inst"},{"key":"BF6600413_CR24","unstructured":"World Health Organization (1979) Handbook for reporting results of cancer treatmentGeneva: World Health Organization"},{"key":"BF6600413_CR25","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/0006-291X(91)90473-K","volume":"176","author":"LJ Xia","year":"1991","unstructured":"Xia, LJ, Folkers, K (1991) Improved methodology to assay carnitine and levels of free and total carnitine in human plasma. Biochem Biophys Res Commun 176: 1617\u20131623","journal-title":"Biochem Biophys Res Commun"},{"key":"BF6600413_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen, SB, Cella, DF, Webster, K, Blendowski, C, Kaplan, E (1997) Measuring fatigue and other anaemia-related symptoms with Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Sympt Manage 13: 63\u201374","journal-title":"J Pain Sympt Manage"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6600413.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600413","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600413.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:43:30Z","timestamp":1684399410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6600413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["BF6600413"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6600413","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}